To hear about similar clinical trials, please enter your email below
Trial Title:
Opiophobia in Postsurgical Adults With Cancer
NCT ID:
NCT06536283
Condition:
Opiophobia
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
13-item Barriers Questionnaire (BQ-13)
Description:
Given by questionnaire
Arm group label:
Opiophobia in Postsurgical Adults
Intervention type:
Other
Intervention name:
Four-item Medication Adherence Questionnaire
Description:
Given by questionnaire
Arm group label:
Opiophobia in Postsurgical Adults
Intervention type:
Other
Intervention name:
14-item Hospital Anxiety and Depression Scale (HADS)
Description:
Given by questionnaire
Arm group label:
Opiophobia in Postsurgical Adults
Summary:
To learn how people who underwent surgery feel about their prescribed opioid medication
after they leave the hospital.
Detailed description:
To explore the barriers and fears related to use of opioids among a population of adults
who underwent surgery for cancer who were prescribed opioids for home use during the
first week following hospital discharge for a surgical treatment of a malignancy.
Criteria for eligibility:
Study pop:
MD Anderson Cancer Center
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
1. Adult patient with cancer admitted for cancer-related surgery
2. inpatient surgical hospital stay lasting at least 23 hours
3. discharged home with a prescription for opioid analgesics
4. able to read, speak, and consent in English.
Exclusion Criteria:
1. Age less than 18 years
2. not discharged with a prescription for opioid analgesia to manage pain
3. individuals for whom there is documentation of inability to provide consent in the
medical record.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
The Univerisity of Texas M. D. Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Eileen Hacker, PHD,RN
Phone:
713-563-4004
Email:
ehacker@mdanderson.org
Investigator:
Last name:
Eileen Hacker, PHD,RN
Email:
Principal Investigator
Start date:
September 16, 2024
Completion date:
December 31, 2026
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Collaborator:
Agency:
Sigma Theta Tau International
Agency class:
Other
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06536283
http://www.mdanderson.org
